File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Exosome-mediated Crosstalk in the Tumor Immune Microenvironment: Critical Drivers of Hepatocellular Carcinoma Progression

TitleExosome-mediated Crosstalk in the Tumor Immune Microenvironment: Critical Drivers of Hepatocellular Carcinoma Progression
Authors
KeywordsCancer therapy
Exosome
Hepatocellular carcinoma
Signal Transduction
Tumor Escape
Tumor immune environment
Issue Date1-Jan-2025
PublisherXia & He Publishing Inc.
Citation
Journal of Clinical and Translational Hepatology, 2025, v. 13, n. 2, p. 143-161 How to Cite?
Abstract

Hepatocellular carcinoma (HCC) is a significant global health issue, ranking as the sixth most prevalent malignancy and the fourth leading cause of cancer-related mortality worldwide. Despite advancements in therapeutic strategies, mortality rates for HCC remain high. The tumor immune microenvironment (TIME) plays a vital role in HCC progression by influencing tumor cell survival and growth. Recent studies highlight the essential role of exosomes in mediating intercellular communication within the TIME, particularly in interactions among tumor cells, immune cells, and fibroblasts. These interactions drive critical aspects of tumor development, including immune escape, angiogenesis, drug resistance, and metastasis. A detailed understanding of the molecular mechanisms by which exosomes modulate the TIME is essential for developing targeted therapies. This review systematically evaluated the roles and regulatory mechanisms of exosomes within the TIME of HCC, examining the impact of both HCC-derived and non-HCC-derived exosomes on various cellular components within the TIME. It emphasized their regulatory effects on cell phenotypes and functions, as well as their roles in HCC progression. The review also explored the potential applications of exosome-based immunotherapies, offering new insights into improving therapeutic strategies for HCC.


Persistent Identifierhttp://hdl.handle.net/10722/356785
ISSN
2023 Impact Factor: 3.1
2023 SCImago Journal Rankings: 0.988
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorGe, Yifei-
dc.contributor.authorJiang, Lixue-
dc.contributor.authorDong, Qingfu-
dc.contributor.authorXu, Yi-
dc.contributor.authorYam, Judy Wai Ping-
dc.contributor.authorZhong, Xiangyu-
dc.date.accessioned2025-06-17T00:35:20Z-
dc.date.available2025-06-17T00:35:20Z-
dc.date.issued2025-01-01-
dc.identifier.citationJournal of Clinical and Translational Hepatology, 2025, v. 13, n. 2, p. 143-161-
dc.identifier.issn2225-0719-
dc.identifier.urihttp://hdl.handle.net/10722/356785-
dc.description.abstract<p>Hepatocellular carcinoma (HCC) is a significant global health issue, ranking as the sixth most prevalent malignancy and the fourth leading cause of cancer-related mortality worldwide. Despite advancements in therapeutic strategies, mortality rates for HCC remain high. The tumor immune microenvironment (TIME) plays a vital role in HCC progression by influencing tumor cell survival and growth. Recent studies highlight the essential role of exosomes in mediating intercellular communication within the TIME, particularly in interactions among tumor cells, immune cells, and fibroblasts. These interactions drive critical aspects of tumor development, including immune escape, angiogenesis, drug resistance, and metastasis. A detailed understanding of the molecular mechanisms by which exosomes modulate the TIME is essential for developing targeted therapies. This review systematically evaluated the roles and regulatory mechanisms of exosomes within the TIME of HCC, examining the impact of both HCC-derived and non-HCC-derived exosomes on various cellular components within the TIME. It emphasized their regulatory effects on cell phenotypes and functions, as well as their roles in HCC progression. The review also explored the potential applications of exosome-based immunotherapies, offering new insights into improving therapeutic strategies for HCC.</p>-
dc.languageeng-
dc.publisherXia & He Publishing Inc.-
dc.relation.ispartofJournal of Clinical and Translational Hepatology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectCancer therapy-
dc.subjectExosome-
dc.subjectHepatocellular carcinoma-
dc.subjectSignal Transduction-
dc.subjectTumor Escape-
dc.subjectTumor immune environment-
dc.titleExosome-mediated Crosstalk in the Tumor Immune Microenvironment: Critical Drivers of Hepatocellular Carcinoma Progression-
dc.typeArticle-
dc.identifier.doi10.14218/JCTH.2024.00302-
dc.identifier.scopuseid_2-s2.0-85217182480-
dc.identifier.volume13-
dc.identifier.issue2-
dc.identifier.spage143-
dc.identifier.epage161-
dc.identifier.eissn2310-8819-
dc.identifier.isiWOS:001367485800001-
dc.identifier.issnl2225-0719-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats